Live Breaking News & Updates on James Januzzi Jr

Stay updated with breaking news from James januzzi jr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitor

Yet empagliflozin gets a boost from a lower risk of total HF events in EMPACT-HF ....

United States , Baylor Scott , James Januzzi Jr , Patrick Ogara , Javed Butler , Nicole Lou , White Research Institute , American College Of Cardiology , Harvard Medical School , American College , New England Journal , Massachusetts General Hospital , Medpage Today , England Journal , Englj Med ,

CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure

Despite some limitations, “the totality of evidence really points towards a benefit,” James Januzzi says. ....

Nordrhein Westfalen , United States , Bad Oeynhausen , Noord Holland , James Januzzi , Diabeteszentrum Nordrhein Westfalen , Finn Gustafsson , James Januzzi Jr , Christian Sohns , Philipp Sommer , American College Of Cardiology , Copenhagen University Hospital , European Society Of Cardiology Congress , European Society , Cardiology Congress , New England Journal , Massachusetts General Hospital , American College ,

SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D

Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation. ....

United States , James Januzzi Jr , Division Of Cardiovascular Medicine , Trinetx Analytics Network , Beth Israel Lahey Health , Cardiovascular Medicine , Lahey Hospital , Medical Center , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Atrial Fibrillation , F Atrial Fibrillation , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Healthcare Technology , Ealth Care Technology , Electronic Medical Record Emr , Electronic Medical Record , Omputerized Medical Reco ,

Lower Entresto Doses Suffice in the Real World

Reassuring findings for patients who don't tolerate the maximum ARNI dose ....

United States , Coll Cardiol , Nicole Lou , Mary Norine Walsh , James Januzzi Jr , Journal Of The American College Cardiology , Harvard Medical School , Vincent Heart Center , City Cardiomyopathy Questionnaire , James Januzzi , Massachusetts General Hospital , American College , Medpage Today ,

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Before TEER or surgery, patients with MR should be optimized on GDMT with sacubitril/valsartan for at least 6 months, say experts. ....

United States , Mitraclip Abbott , Jamesl Januzzi Jr , Los Angeles , Gregg Fonarow , James Januzzi Jr , G Michael Felker , Heart Failure Society Of America , Md University Of California , Md Duke Clinical Research Institute , Massachusetts General Hospital , Heart Failure Society , Duke Clinical Research Institute ,